| Self-assembled hyaluronic acid nanoparticles for active tumor targeting KY Choi, H Chung, KH Min, HY Yoon, K Kim, JH Park, IC Kwon, SY Jeong Biomaterials 31 (1), 106-114, 2010 | 668 | 2010 |
| Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy KY Choi, HY Yoon, JH Kim, SM Bae, RW Park, YM Kang, IS Kim, IC Kwon, ... ACS nano 5 (11), 8591-8599, 2011 | 419 | 2011 |
| PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo KY Choi, KH Min, HY Yoon, K Kim, JH Park, IC Kwon, K Choi, SY Jeong Biomaterials 32 (7), 1880-1889, 2011 | 375 | 2011 |
| Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel HJ Cho, HY Yoon, H Koo, SH Ko, JS Shim, JH Lee, K Kim, IC Kwon, ... Biomaterials 32 (29), 7181-7190, 2011 | 342 | 2011 |
| Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery T Thambi, VG Deepagan, HY Yoon, HS Han, SH Kim, S Son, DG Jo, ... Biomaterials 35 (5), 1735-1743, 2014 | 333 | 2014 |
| Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy HY Yoon, H Koo, KY Choi, SJ Lee, K Kim, IC Kwon, JF Leary, K Park, ... Biomaterials 33 (15), 3980-3989, 2012 | 303 | 2012 |
| Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin HJ Cho, IS Yoon, HY Yoon, H Koo, YJ Jin, SH Ko, JS Shim, K Kim, ... Biomaterials 33 (4), 1190-1200, 2012 | 288 | 2012 |
| Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery JH Park, HJ Cho, HY Yoon, IS Yoon, SH Ko, JS Shim, JH Cho, JH Park, ... Journal of Controlled Release 174, 98-108, 2014 | 206 | 2014 |
| Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer KY Choi, EJ Jeon, HY Yoon, BS Lee, JH Na, KH Min, SY Kim, SJ Myung, ... Biomaterials 33 (26), 6186-6193, 2012 | 183 | 2012 |
| Bioreducible block copolymers based on poly (ethylene glycol) and poly (γ-benzyl L-glutamate) for intracellular delivery of camptothecin T Thambi, HY Yoon, K Kim, IC Kwon, CK Yoo, JH Park Bioconjugate chemistry 22 (10), 1924-1931, 2011 | 158 | 2011 |
| Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: Sequential delivery of doxorubicin and Bcl-2 siRNA HY Yoon, S Son, SJ Lee, DG You, JY Yhee, JH Park, M Swierczewska, ... Scientific reports 4 (1), 6878, 2014 | 149 | 2014 |
| Hydrotropic hyaluronic acid conjugates: synthesis, characterization, and implications as a carrier of paclitaxel G Saravanakumar, KY Choi, HY Yoon, K Kim, JH Park, IC Kwon, K Park International journal of pharmaceutics 394 (1-2), 154-161, 2010 | 140 | 2010 |
| Engineering nanoparticle strategies for effective cancer immunotherapy HY Yoon, ST Selvan, Y Yang, MJ Kim, DK Yi, IC Kwon, K Kim Biomaterials 178, 597-607, 2018 | 134 | 2018 |
| Hyaluronic acid nanoparticles for active targeting atherosclerosis GY Lee, JH Kim, KY Choi, HY Yoon, K Kim, IC Kwon, K Choi, BH Lee, ... Biomaterials 53, 341-348, 2015 | 128 | 2015 |
| Extracellular matrix remodeling in vivo for enhancing tumor-targeting efficiency of nanoparticle drug carriers using the pulsed high intensity focused ultrasound S Lee, H Han, H Koo, JH Na, HY Yoon, KE Lee, H Lee, H Kim, IC Kwon, ... Journal of Controlled Release 263, 68-78, 2017 | 123 | 2017 |
| Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery HY Yoon, H Koo, KY Choi, IC Kwon, K Choi, JH Park, K Kim Biomaterials 34 (21), 5273-5280, 2013 | 123 | 2013 |
| Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy MK Shim, J Park, HY Yoon, S Lee, W Um, JH Kim, SW Kang, JW Seo, ... Journal of Controlled Release 294, 376-389, 2019 | 120 | 2019 |
| Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo HS Han, J Lee, HR Kim, SY Chae, M Kim, G Saravanakumar, HY Yoon, ... Journal of Controlled Release 168 (2), 105-114, 2013 | 117 | 2013 |
| Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy S Lim, J Park, MK Shim, W Um, HY Yoon, JH Ryu, DK Lim, K Kim Theranostics 9 (25), 7906, 2019 | 103 | 2019 |
| Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy J Choi, MK Shim, S Yang, HS Hwang, H Cho, J Kim, WS Yun, Y Moon, ... ACS nano 15 (7), 12086-12098, 2021 | 98 | 2021 |
Kwangmeyung KimEwha Womans UniversityVerified email at ewha.ac.kr
